METTL3 promotes esophageal squamous cell carcinoma progression and reduces chemosensitivity to paclitaxel through the CASP9/BIRC3-dependent apoptosis pathway.

Pengxiang Ji, Bo Wan, Minghui Gao, Shaohua Yin, Han Wu, Junjie Wang, Yuting Ma, Weihua Xu, Minghua Wang

Abstract read

In one paragraph

Article in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review).International journal of oncology · 2026
Review
Identification of serum 5'tRF-Val as a promising non-invasive biomarker for early detection of esophageal cancer.Scientific reports · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pengxiang JiDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Bo WanDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Minghui GaoDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Shaohua YinDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Han WuDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Junjie WangDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Yuting MaCAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, China.

Weihua XuDepartment of Thoracic and Cardiac Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.

Minghua WangDepartment of Biochemistry and Molecular Biology, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41262526

DOI10.1016/j.gendis.2025.101693

PMCPMC12624589

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.